Inspiringly, inferred from the data associated with MK2 inhibitor IV, we found the inhibitor manifesting remarkable reduction of MM cellular growth, colony formation and ABC transporter drug pump (Figure 3). This evidence concerns the gene MAPKAPK2 and Miyoshi myopathy.